Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus - PubMed (original) (raw)
Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus
A van der Burgh et al. Gut. 1996 Jul.
Abstract
Background: Barrett's oesophagus carries a 30-fold to 40-fold increased risk of oesophageal cancer. It is unknown whether endoscopic surveillance programmes reduce mortality from oesophageal cancer.
Methods: A cohort study was undertaken of all 166 patients in whom the diagnosis Barrett's oesophagus had been established between 1973 and 1986.
Results: One hundred and fifty five of 166 patients could be traced (93%). During a mean follow up of 9.3 years (amounting to 1440 patient years) eight patients had developed oesophageal cancer at random intervals (one case in 180 patient years). All but one of the tumours were diagnosed at endoscopy for symptoms, three in the stage of carcinoma in situ. Risk factors for the development of oesophageal cancer were extensive Barrett's oesophagus exceeding 10 cm (p = 0.02) and Barrett's ulcer at the time of intake (p = 0.009). Seventy six patients were alive; three had undergone surgery for oesophageal cancer and were without recurrence respectively, 12.8 years, 12.1 years, and 7 months postoperatively. Seventy nine patients had died; five of them had developed oesophageal cancer, but in only two cases this had been the cause of death (2.5%).
Conclusions: Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. The patients of this cohort would not have benefited from an endoscopic surveillance programme.
Comment in
- Oesophageal cancer in patients with Barrett's oesophagus.
Hoeffel JC. Hoeffel JC. Gut. 1997 Nov;41(5):723. doi: 10.1136/gut.41.5.723a. Gut. 1997. PMID: 9432480 Free PMC article. No abstract available.
Similar articles
- A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillance.
Gudlaugsdottir S, van Blankenstein M, Dees J, Wilson JH. Gudlaugsdottir S, et al. Eur J Gastroenterol Hepatol. 2001 Jun;13(6):639-45. doi: 10.1097/00042737-200106000-00005. Eur J Gastroenterol Hepatol. 2001. PMID: 11434588 - Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance.
Rana PS, Johnston DA. Rana PS, et al. Dis Esophagus. 2000;13(1):28-31. doi: 10.1046/j.1442-2050.2000.00069.x. Dis Esophagus. 2000. PMID: 11005328 Review. - Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
Quera R, O'Sullivan K, Quigley EM. Quera R, et al. Endoscopy. 2006 Feb;38(2):162-9. doi: 10.1055/s-2005-921184. Endoscopy. 2006. PMID: 16479424 - Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
Pohl H, Pech O, Arash H, Stolte M, Manner H, May A, Kraywinkel K, Sonnenberg A, Ell C. Pohl H, et al. Gut. 2016 Feb;65(2):196-201. doi: 10.1136/gutjnl-2015-309220. Epub 2015 Jun 25. Gut. 2016. PMID: 26113177 - Ablation of Barrett's oesophagus: towards improved outcomes for oesophageal cancer?
Mayne GC, Bright T, Hussey DJ, Watson DI. Mayne GC, et al. ANZ J Surg. 2012 Sep;82(9):592-8. doi: 10.1111/j.1445-2197.2012.06151.x. Epub 2012 Aug 20. ANZ J Surg. 2012. PMID: 22901306 Review.
Cited by
- A microRNA Signature Identifies Patients at Risk of Barrett Esophagus Progression to Dysplasia and Cancer.
Saller J, Jiang K, Xiong Y, Yoder SJ, Neill K, Pimiento JM, Pena L, Corbett FS, Magliocco A, Coppola D. Saller J, et al. Dig Dis Sci. 2022 Feb;67(2):516-523. doi: 10.1007/s10620-021-06863-0. Epub 2021 Mar 13. Dig Dis Sci. 2022. PMID: 33713247 Free PMC article. - Circular stripes were more common in Barrett's esophagus after acetic acid staining.
Sun Y, Ma S, Fang L, Wang J, Dong L. Sun Y, et al. BMC Gastroenterol. 2018 Jan 25;18(1):17. doi: 10.1186/s12876-018-0745-7. BMC Gastroenterol. 2018. PMID: 29370762 Free PMC article. - Short-Segment Barrett's Esophagus and Adenocarcinoma.
Rastogi A, Sharma P. Rastogi A, et al. Gastroenterol Hepatol (N Y). 2006 Feb;2(2):134-139. Gastroenterol Hepatol (N Y). 2006. PMID: 28286441 Free PMC article. - Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort.
Cook MB, Coburn SB, Lam JR, Taylor PR, Schneider JL, Corley DA. Cook MB, et al. Gut. 2018 Mar;67(3):418-529. doi: 10.1136/gutjnl-2016-312223. Epub 2017 Jan 4. Gut. 2018. PMID: 28053055 Free PMC article. - Progression of Barrett's esophagus toward esophageal adenocarcinoma: an overview.
Schoofs N, Bisschops R, Prenen H. Schoofs N, et al. Ann Gastroenterol. 2017;30(1):1-6. doi: 10.20524/aog.2016.0091. Epub 2016 Sep 30. Ann Gastroenterol. 2017. PMID: 28042232 Free PMC article. Review.
References
- Gut. 1991 Dec;32(12):1441-6 - PubMed
- Gastroenterology. 1992 Apr;102(4 Pt 1):1212-9 - PubMed
- Gut. 1992 Sep;33(9):1155-8 - PubMed
- Cancer. 1993 Aug 15;72(4):1155-8 - PubMed
- Eur J Gastroenterol Hepatol. 1995 Jan;7(1):81-4 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical